Wan‐Chun Chang

1.1k total citations
21 papers, 552 citations indexed

About

Wan‐Chun Chang is a scholar working on Pharmacology, Rheumatology and Molecular Biology. According to data from OpenAlex, Wan‐Chun Chang has authored 21 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Wan‐Chun Chang's work include Drug-Induced Adverse Reactions (7 papers), Urticaria and Related Conditions (5 papers) and Inflammasome and immune disorders (3 papers). Wan‐Chun Chang is often cited by papers focused on Drug-Induced Adverse Reactions (7 papers), Urticaria and Related Conditions (5 papers) and Inflammasome and immune disorders (3 papers). Wan‐Chun Chang collaborates with scholars based in Taiwan, Canada and China. Wan‐Chun Chang's co-authors include Wen‐Hung Chung, Wen‐Hung Chung, Yeong‐Jian Jan Wu, Der‐Yuan Chen, Ya‐Chung Tian, Chee‐Jen Chang, Yu‐Jr Lin, Mu-Tzu Chu, Chih‐Hsun Yang and Rosaline Chung‐Yee Hui and has published in prestigious journals such as The Annual Review of Pharmacology and Toxicology, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

Wan‐Chun Chang

21 papers receiving 542 citations

Peers

Wan‐Chun Chang
M.H. Lee Australia
Mohsen Elshahaly Egypt
Taiichi Kaku Japan
G. Canto Spain
R A Hazelton Australia
Carol Astbury United Kingdom
Lin Han China
Yoon Su Lee South Korea
G Czerniawska-Mysik Poland
William H. Vaughn United States
M.H. Lee Australia
Wan‐Chun Chang
Citations per year, relative to Wan‐Chun Chang Wan‐Chun Chang (= 1×) peers M.H. Lee

Countries citing papers authored by Wan‐Chun Chang

Since Specialization
Citations

This map shows the geographic impact of Wan‐Chun Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Chun Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Chun Chang more than expected).

Fields of papers citing papers by Wan‐Chun Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Chun Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Chun Chang. The network helps show where Wan‐Chun Chang may publish in the future.

Co-authorship network of co-authors of Wan‐Chun Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Chun Chang. A scholar is included among the top collaborators of Wan‐Chun Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Chun Chang. Wan‐Chun Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Wan‐Chun, et al.. (2025). Amino Acid Stress Response Genes Contribute to a 25‐Fold Increased Risk of L‐Asparaginase–Induced Hypersensitivity. Pediatric Blood & Cancer. 72(6). e31668–e31668. 1 indexed citations
2.
Arab, Ali, Bahareh Kashani, Wan‐Chun Chang, et al.. (2024). Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4. Computers in Biology and Medicine. 183. 109324–109324. 5 indexed citations
3.
Liu, Yu, Chuang‐Wei Wang, Chun‐Bing Chen, et al.. (2023). DNA methylation of ITGB2 contributes to allopurinol hypersensitivity. Clinical Immunology. 248. 109250–109250. 5 indexed citations
4.
Chu, Mu-Tzu, et al.. (2023). Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators. Biomedicines. 11(1). 177–177. 17 indexed citations
5.
Shen, Yen‐Wen, Wan‐Chun Chang, Heng‐Li Huang, et al.. (2021). Assessment of the Retromolar Canal in Taiwan Subpopulation: A Cross-Sectional Cone-Beam Computed Tomography Study in a Medical Center. Tomography. 7(2). 219–227. 4 indexed citations
6.
7.
Chang, Wan‐Chun, Wen‐Hung Chung, Bruce Carleton, & Wen‐Hung Chung. (2020). An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Expert Opinion on Drug Metabolism & Toxicology. 16(8). 723–734. 10 indexed citations
8.
Chu, Mu-Tzu, Chuang‐Wei Wang, Wan‐Chun Chang, et al.. (2020). Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. Journal of Investigative Dermatology. 141(6). 1461–1472.e10. 18 indexed citations
9.
Chen, Yi‐Ming, Wei‐Ting Hung, Wan‐Chun Chang, et al.. (2020). Genetic Association and Expression Correlation between Colony‐Stimulating Factor 1 Gene Encoding M‐CSF and Adult‐Onset Still’s Disease. Journal of Immunology Research. 2020(1). 8640719–8640719. 7 indexed citations
10.
Chang, Wan‐Chun, Mu-Tzu Chu, Chih–Yuan Hsu, et al.. (2019). Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation. The American Journal of Chinese Medicine. 47(1). 135–151. 49 indexed citations
11.
Ng, Chau Yee, Chuang‐Wei Wang, Wen‐Hung Chung, et al.. (2016). Impact of the HLA-B58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions. Journal of Investigative Dermatology. 136(7). 1373–1381. 66 indexed citations
12.
Chang, Wan‐Chun, Yeong‐Jian Jan Wu, Wen‐Hung Chung, et al.. (2016). Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Lara D. Veeken. 56(3). kew337–kew337. 40 indexed citations
13.
Chung, Wen‐Hung, Wan‐Chun Chang, Sophie L. Stocker, et al.. (2014). Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Annals of the Rheumatic Diseases. 74(12). 2157–2164. 144 indexed citations
14.
Yeh, Chun‐Nan, Wen‐Hung Chung, Shih‐Chi Su, et al.. (2014). Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction. Journal of Investigative Dermatology. 134(11). 2768–2775. 20 indexed citations
15.
Hui, Rosaline Chung‐Yee, Tony Wu, Wan‐Chun Chang, et al.. (2013). Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations. Journal of Dermatological Science. 73(2). 101–109. 72 indexed citations
16.
Gao, Rui, et al.. (2010). Molecular identification of a phytoplasma associated with Elm witches’‐broom in China. Forest Pathology. 41(5). 355–360. 6 indexed citations
17.
Wu, Wei, et al.. (2009). Malignant transformation of extragonadal endometriosis: a case report.. PubMed. 30(5). 563–5. 3 indexed citations
18.
Chang, Wan‐Chun, et al.. (1999). 2,3,5-Triphenyltetrazolium reduction in the viability assay of Ulva fasciata (Chlorophyta) in response to salinity stress. Zhōngyāng yánjiūyuàn zhíwùxué huikān/Zhōngyāng yánjiūyuàn zhíwùxué huikān. 21 indexed citations
19.
Changchien, C.‐S., et al.. (1997). Endoscopic Diagnosis of Small Intestinal Amyloidosis. Endoscopy. 29(9). S 57–S 57. 3 indexed citations
20.
Chang, Wan‐Chun, et al.. (1996). Applying case mix adjustment in profiling primary care physician performance.. PubMed. 22(4). 1–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.H. Lee Breakdown of academic impact, for papers by Mohsen Elshahaly Breakdown of academic impact, for papers by Taiichi Kaku Breakdown of academic impact, for papers by G. Canto Breakdown of academic impact, for papers by R A Hazelton Breakdown of academic impact, for papers by Carol Astbury Breakdown of academic impact, for papers by Lin Han Breakdown of academic impact, for papers by Yoon Su Lee Breakdown of academic impact, for papers by G Czerniawska-Mysik Breakdown of academic impact, for papers by William H. Vaughn
Rankless by CCL
2026